Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Hybrid and Bismuth Containing Quadruple Therapies for Helicobacter Pylori Eradication
NCT02541864Completed
- Sponsor
- Kaohsiung Veterans General Hospital
- Start
- Jul 2013
- Primary completion
- Aug 2015
- Modality
- DNA Intercalators/Alkylators
01
Overview
Randomised trial of pantoprazole, amoxicillin, clarithromycin, metronidazole, bismuth subcitrate and 1 more in Helicobacter pylori infection (2 arms), sponsored by Kaohsiung Veterans General Hospital. Primary endpoint: Number of Participants in Which H. Pylori Was Eradicated at 6 weeks. Started Jul 2013; status: completed.
02
Drugs
pantoprazoleamoxicillinclarithromycinmetronidazolebismuth subcitrate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02541864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02541864.